Representative Matters /
Reverse Acquisition of Ruthigen, Inc.
Reverse Acquisition of Ruthigen, Inc.
Represented Pulmatrix Inc., a clinical stage biotechnology company, in its public merger with Ruthigen, Inc.
Participating Lawyers
Matthew L. Fry
Partner | Co-Chair - Capital Markets and Securities Practice Group
T +1 214.651.5443 Email
Rick A. Werner
Partner | Co-Chair - Capital Markets and Securities Practice Group
T +1 212.659.4974 Email